
Contact us
About company
GO Therapeutics is the only company with the technologies, platforms and know-how to harness the power of the cancer glycoproteome to generate exceptionally tumor-specific antibodies for cancer immunotherapies. By making antibodies to hybrid antigens combining a tumor’s up-regulated protein expression with a protein’s aberrant glycosylation pattern, we are able to dramatically increase tumor specificity. Our technology clears the hurdles for making drugs that are extremely specific to the cancer cell.
Unknown
Unknown
Not verified company